Literature DB >> 22550953

A robust method for estimating optimal treatment regimes.

Baqun Zhang1, Anastasios A Tsiatis, Eric B Laber, Marie Davidian.   

Abstract

A treatment regime is a rule that assigns a treatment, among a set of possible treatments, to a patient as a function of his/her observed characteristics, hence "personalizing" treatment to the patient. The goal is to identify the optimal treatment regime that, if followed by the entire population of patients, would lead to the best outcome on average. Given data from a clinical trial or observational study, for a single treatment decision, the optimal regime can be found by assuming a regression model for the expected outcome conditional on treatment and covariates, where, for a given set of covariates, the optimal treatment is the one that yields the most favorable expected outcome. However, treatment assignment via such a regime is suspect if the regression model is incorrectly specified. Recognizing that, even if misspecified, such a regression model defines a class of regimes, we instead consider finding the optimal regime within such a class by finding the regime that optimizes an estimator of overall population mean outcome. To take into account possible confounding in an observational study and to increase precision, we use a doubly robust augmented inverse probability weighted estimator for this purpose. Simulations and application to data from a breast cancer clinical trial demonstrate the performance of the method.
© 2012, The International Biometric Society.

Entities:  

Mesh:

Year:  2012        PMID: 22550953      PMCID: PMC3556998          DOI: 10.1111/j.1541-0420.2012.01763.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  13 in total

1.  Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content.

Authors:  Liliana Orellana; Andrea Rotnitzky; James M Robins
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

2.  Doubly robust estimation in missing data and causal inference models.

Authors:  Heejung Bang; James M Robins
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

3.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

4.  Regret-regression for optimal dynamic treatment regimes.

Authors:  Robin Henderson; Phil Ansell; Deyadeen Alshibani
Journal:  Biometrics       Date:  2010-12       Impact factor: 2.571

5.  Reinforcement learning design for cancer clinical trials.

Authors:  Yufan Zhao; Michael R Kosorok; Donglin Zeng
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

6.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

7.  Variable selection for qualitative interactions in personalized medicine while controlling the family-wise error rate.

Authors:  Lacey Gunter; Ji Zhu; Susan Murphy
Journal:  J Biopharm Stat       Date:  2011-11       Impact factor: 1.051

8.  Improving efficiency and robustness of the doubly robust estimator for a population mean with incomplete data.

Authors:  Weihua Cao; Anastasios A Tsiatis; Marie Davidian
Journal:  Biometrika       Date:  2009-08-07       Impact factor: 2.445

9.  Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.

Authors:  B Fisher; C Redmond; A Brown; D L Wickerham; N Wolmark; J Allegra; G Escher; M Lippman; E Savlov; J Wittliff
Journal:  J Clin Oncol       Date:  1983-04       Impact factor: 44.544

10.  Testing for qualitative interactions between treatment effects and patient subsets.

Authors:  M Gail; R Simon
Journal:  Biometrics       Date:  1985-06       Impact factor: 2.571

View more
  137 in total

1.  Optimizing delivery of a behavioral pain intervention in cancer patients using a sequential multiple assignment randomized trial SMART.

Authors:  Sarah A Kelleher; Caroline S Dorfman; Jen C Plumb Vilardaga; Catherine Majestic; Joseph Winger; Vicky Gandhi; Christine Nunez; Alyssa Van Denburg; Rebecca A Shelby; Shelby D Reed; Susan Murphy; Marie Davidian; Eric B Laber; Gretchen G Kimmick; Kelly W Westbrook; Amy P Abernethy; Tamara J Somers
Journal:  Contemp Clin Trials       Date:  2017-04-11       Impact factor: 2.226

2.  Doubly Robust Learning for Estimating Individualized Treatment with Censored Data.

Authors:  Y Q Zhao; D Zeng; E B Laber; R Song; M Yuan; M R Kosorok
Journal:  Biometrika       Date:  2015-03-01       Impact factor: 2.445

3.  Tree based weighted learning for estimating individualized treatment rules with censored data.

Authors:  Yifan Cui; Ruoqing Zhu; Michael Kosorok
Journal:  Electron J Stat       Date:  2017-10-18       Impact factor: 1.125

4.  Set-valued dynamic treatment regimes for competing outcomes.

Authors:  Eric B Laber; Daniel J Lizotte; Bradley Ferguson
Journal:  Biometrics       Date:  2014-01-08       Impact factor: 2.571

5.  Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: with an Application to Treating Type 2 Diabetes Patients with Insulin Therapies.

Authors:  Yuanjia Wang; Haoda Fu; Donglin Zeng
Journal:  J Am Stat Assoc       Date:  2017-03-31       Impact factor: 5.033

6.  TARGETED SEQUENTIAL DESIGN FOR TARGETED LEARNING INFERENCE OF THE OPTIMAL TREATMENT RULE AND ITS MEAN REWARD.

Authors:  Antoine Chambaz; Wenjing Zheng; Mark J van der Laan
Journal:  Ann Stat       Date:  2017-12-15       Impact factor: 4.028

7.  Evaluating marker-guided treatment selection strategies.

Authors:  Roland A Matsouaka; Junlong Li; Tianxi Cai
Journal:  Biometrics       Date:  2014-04-29       Impact factor: 2.571

8.  A single-index model with multiple-links.

Authors:  Hyung Park; Eva Petkova; Thaddeus Tarpey; R Todd Ogden
Journal:  J Stat Plan Inference       Date:  2019-07-04       Impact factor: 1.111

9.  Deep Reinforcement Learning for Dynamic Treatment Regimes on Medical Registry Data.

Authors:  Ying Liu; Brent Logan; Ning Liu; Zhiyuan Xu; Jian Tang; Yanzhi Wang
Journal:  Healthc Inform       Date:  2017-08

10.  Bayesian predictive modeling for genomic based personalized treatment selection.

Authors:  Junsheng Ma; Francesco C Stingo; Brian P Hobbs
Journal:  Biometrics       Date:  2015-11-17       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.